ClinicalTrials.gg
CompletedNCT00340028Updated Jan 1, 2025

Hormonal Changes in Early Pregnancy

An observational study in Pregnancy, sponsored by National Institute of Environmental Health Sciences (NIEHS). Completed at 2 sites in United States. Open to female participants aged 25 Years to 35 Years. Per ClinicalTrials.gov, last updated 2025-01-01.

Sponsored by National Institute of Environmental Health Sciences (NIEHS) · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Ages
25 Years to 35 Years
Sex
Female
01

Study summary

This study will analyze hormones in early pregnancy. Hormonal changes in early pregnancy reflect the quality of implantation in the uterus of the fertilized egg, the function of the corpus luteum (mass of hormone-secreting tissue that forms immediately after ovulation) and placenta, and the health of the embryo. It will determine the following:

  • Whether early pregnancy hormones vary by characteristics of the mother
  • Whether early pregnancy hormones differ for pregnancies with male or female babies
  • Whether early pregnancy hormones can predict the gestational age (age of the baby during pregnancy) and the baby's birth weight
  • Hormone activity at the time pregnancy symptoms begin
  • How the contribution of the corpus luteum changes during the pregnancy in different women

Stored urine specimens collected from women who participated in the North Carolina Early Pregnancy Study in the 1980s will be used for this study. In addition, to evaluate the quality of the stored samples, new specimens will be collected from women currently enrolled in the University of North Carolina's Right from the Start study. Candidates must be white women not of Latino or Hispanic origin who are between 25 and 35 years of age and who are planning to become pregnant within a few months' time. They must be non-smokers, have regular menstrual cycles, no known fertility problems and no major chronic disease.

Urine specimens are analyzed for hormone levels and other changes in early pregnancy that can be measured in urine. Women providing new urine specimens do the following:

Pre-Pregnancy

The pre-pregnancy part of the study lasts through no more than three consecutive menstrual cycles. Participants who do not become pregnant after three menstrual cycles end the study at that time.

  • Have a short interview with a study staff member
  • Complete a daily diary, recording any vaginal bleeding or spotting, health status, and use of medications, and mail the diary to the study office once a week
  • Use an ovulation testing kit for up to 7 days during their menstrual cycle
  • Call the study staff within the first 24 hours of becoming pregnant

Pregnancy

The pregnancy part of the study lasts about 5 weeks.

  • Continue to complete daily diary records for weekly pickup by staff member
  • Collect urine samples daily and store them in the freezer for weekly pickup by staff member
  • Have 1 to 2 tablespoons of blood drawn at home weekly for 4 weeks
  • Have a brief follow-up telephone interview around week 12 of their pregnancy

Urine samples are analyzed for hormones such as human chorionic gonadotropin, estrone-3-glucuronide, and pregnanedrol glucuronide. White blood cells are stored for DNA to study such things as genes controlling hormone metabolism.

...

Read the detailed description

Daily first morning urine specimens were collected throughout the first 8-9 weeks of 151 clinical pregnancies. These specimens are now approximately 20 years in storage, and the stability of markers of placental and corpus luteum function are not known. We will collect new urine specimens for 20 pregnancies to serve as a reference to evaluate the quality of those stored samples.

02

Conditions studied

  • Pregnancy

Keywords

  • Ovulation
  • Diary Record
  • Urine Collection
  • Blood Collection
  • Hormone
  • Natural History
03

In context

Lead sponsor

National Institute of Environmental Health Sciences (NIEHS) is the lead sponsor of 183 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Stored urine specimens collected from women who participated in the North Carolina Early Pregnancy Study in the 1980s will be used for this study. In addition, to evaluate the quality of the stored samples, new specimens will be collected from women currently enrolled in the University of North Carolina's Right from the Start study. Candidates must be white women not of Latino or Hispanic origin who are between 25 and 35 years of age and who are planning to become pregnant within a few months' time. They must be non-smokers, have regular menstrual cycles, no known fertility problems and no major chronic disease.

Eligibility criteria

  • INCLUSION/EXCLUSION CRITERIA:

We will recruit from the pre-pregnancy participants in the Right From the Start UNC study entitled, Consequences and Course of Uterine Fibroid in Pregnancies.

The women will be selected to be similar to the majority of women in the NC-EPS because we need to have a comparable sample of women in order to best compare hormone levels.

Entry requirements will be:

white (including Hispanic and latino), age 25-35, regular menstrual cycles, nonsmoker (i.e., no smoking in past year), no major chronic disease, no known fertility problems, no more than 3 months of trying for this current pregnancy.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (actual)

Groups and cohorts

  • Women in Early Pregnancy

    Women enrolled in the University of North Carolina's Right from the Start study are followed while trying to become pregnant and through 9 weeks of pregnancy

06

What researchers measure

Primary outcomes

  1. We will assay both old urines and new urines for the estrogen metabolite, the progesterone metabolite, and hCG.

    no disease treatment monitored

    Time frame: Time points were daily for urine and weekly blood

07

Study locations

2 sites
  • University of North Carolina
    Chapel Hill, North Carolina, United States
  • NIEHS, Research Triangle Park
    Research Triangle Park, North Carolina 27709, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00340028
Responsible party
Sponsor
First posted
Jun 21, 2006
Start date
Jan 18, 2005
Primary completion
Feb 24, 2006
Completion
Apr 22, 2014
Last update
Jan 1, 2025

Study contacts

Donna D Baird, Ph.D.
principal investigator · National Institute of Environmental Health Sciences (NIEHS)

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion